Supporting the
delivery of industry-
informed biopharma
curriculum
What do we do?
At CASTL, we foster dynamic and industry-informed bioprocessing curricula in collaboration with post-secondary institutions. Our specialized focus on biopharma manufacturing equips students with invaluable industry-specific training, empowering them with a competitive edge and the essential credentials to thrive in their careers.
How do we do it?
Embark on a journey of diverse training and
development partnership possibilities with CASTL,
offering the following pathways:
- Integrate biomanufacturing excellence into your institution's credit course
program with tailored course components. - Opt for turn-key extra-curricular programming, inclusive of preparation,
delivery, and evaluation. - Collaborate on credit courses, enriched with online learning modules and
immersive hands-on practical training at CASTL.
CBRF Hub Partners
The CBRF-BRIF funds are a crucial element in supporting the Government of Canada’s Biomanufacturing and Life Sciences Strategy. This program is designed to build on existing assets and infrastructure, promoting highly collaborative projects including partners from academia, industry, government, and the nonprofit sector, to prepare Canada for the next pandemic and build our national biomanufacturing capacity.
CASTL is pleased to be a partner in the following hubs:
Canada’s Immuno-Engineering and Biomanufacturing Hub: Engineering Immunity for Pandemic Response
Led by The University of British Columbia. Helping develop next-generation immune-based therapeutics that can be manufactured domestically using the latest innovations in biomanufacturing in response to pandemics.
Eastern Canada Pandemic Preparedness Hub (ECaPPH)
Led by the University of Montreal. Increasing the agility, connectivity and growth of the biomanufacturing and life sciences sector to ensure that Canada is prepared for future pandemics and public health crises.
Canadian Pandemic Preparedness Hub (CP2H)
Led by the University of Ottawa and McMaster University. Catalyzing research and biomanufacturing innovations to help Canada produce vaccines, therapeutics and diagnostics ahead of future pandemics.
Canadian Hub for Health Intelligence & Innovation in Infectious Diseases (HI3)
Led by the University of Toronto. Advancing the concept of “personalized and precise medicine” to influence the development of vaccines, therapeutics and other public health interventions.
Our Current
Post-Secondary Partners
|
|
|
CASTL partnered with the University of British Columbia School of Biomedical Engineering (UBC SBME) to deliver ‘Introduction to Biopharmaceutical Manufacturing’ to undergraduate students. The course was designed to provide students with a comprehensive understanding of the scientific and engineering challenges present in the manufacturing of biopharmaceutical products. |
|
|
|
The University of Prince Edward Island (UPEI) has developed a Minor in Biotechnology. Launched in January 2022, this program provides students with skills that are valued by industry stakeholders. It also serves as a gateway for students to pursue further studies related to CASTL priority areas including the biotechnology articulation program. |
|
|
|
BCIT is partnering with CASTL to create a new biomanufacturing training facility at BCIT to deliver training and build the talent pool to meet the needs of the growing life sciences and biomanufacturing industry. The new National Biomanufacturing Training Centre (NBTC) will be the first of its kind in B.C. (Opening Spring 2024). |
Unlock a world of knowledge.
Subscribe to our newsletter today.
 |
 |
National Headquarters
302-134 Kent Street
Charlottetown, PEI
C1A 8R8
Canada
Charlottetown
35 Regis Duffy Drive, Unit 1
Charlottetown, PEI
C1E 0K6
Montreal
4100 Molson Street, Suite 120
Montréal,QC
H1Y 3N1
Vancouver
CASTL @ BCIT
Lead National Partner
Global Partner
